Global CBD Skincare Market 2020-2024

Global CBD Skincare Market 2020-2024

The author has been monitoring the global CBD skincare market and it is poised to grow by USD 1.64 bn during 2020-2024, progressing at a CAGR of 33% during the forecast period. The reports on global CBD skincare market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by benefits of CBD in skincare. In addition, growing demand among millennial and middle-aged populations is anticipated to boost the growth of the global CBD skincare market as well.

Market Segmentation

The global CBD skincare market is segmented as below:

Type

Oils
Cream, Moisturizer, And Cleanser
Mask, Serum, And Lotion

Source

Hemp
Marijuana

Geographic segmentation

North America
APAC
Europe
South America
MEA

Key Trends for global CBD skincare market growth
This study identifies growing demand among millennial and middle-aged populations as the prime reasons driving the global CBD skincare market growth during the next few years.

Prominent vendors in global CBD skincare market
We provide a detailed analysis of around 25 vendors operating in the global CBD skincare market, including some of the vendors such as Cannuka LLC, Cronos Group Inc., Elixinol Global Ltd., Endoca BV, Isodiol International Inc., Josie Maran Cosmetics LLC, Khiron Life Sciences Corp., L’Oréal SA, Medical Marijuana Inc. and The CBD Skincare Co.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

01: EXECUTIVE SUMMARY

02: SCOPE OF THE REPORT

Preface
Currency conversion rates for US$

03: MARKET LANDSCAPE

Market ecosystem
Market characteristics
Market segmentation analysis
Value chain analysis

04: MARKET SIZING

Market definition
Market sizing 2019
Market size and forecast 2019-2024
Market outlook

05: FIVE FORCES ANALYSIS

Bargaining power of buyers
Bargaining power of suppliers
Threat of new entrants
Threat of substitutes
Threat of rivalry
Market condition

06: MARKET SEGMENTATION BY END-USER

Market segmentation by end-user
Comparison by end-user
Pharmaceutical companies - Market size and forecast 2019-2024
Other organizations - Market size and forecast 2019-2024
Market opportunity by end-user

07: CUSTOMER LANDSCAPE

08: GEOGRAPHIC LANDSCAPE

Geographic segmentation
Geographic comparison
North America - Market size and forecast 2019-2024
Europe - Market size and forecast 2019-2024
Asia - Market size and forecast 2019-2024
ROW - Market size and forecast 2019-2024
Key leading countries
Market opportunity

09: DECISION FRAMEWORK

10: DRIVERS AND CHALLENGES

Market drivers
Market challenges

11: MARKET TRENDS

Advent of AI in clinical research
Increasing outsourcing activities to CROs
Increasing adoption of cloud technologies in pharmaceutical production
and testing

12: VENDOR LANDSCAPE

Overview
Landscape disruption
Competitive scenario

13: VENDOR ANALYSIS

Vendors covered
Vendor classification
Market positioning of vendors
Bilcare Ltd.
Caligor Coghlan Pharma Services
Corden Pharma International GmbH
Mawdsley-Brooks & Co. Ltd.
PCI Pharma Services
Piramal Enterprises Ltd.
Sentry BioPharma Services
Sharp
The WestRock group
Thermo Fisher Scientific Inc.

14: APPENDIX

Research methodology
List of abbreviations
Definition of market positioning of vendors

List of Exhibits

Exhibit 01: Vendors: Key offerings
Exhibit 02: Global healthcare market
Exhibit 03: Segments of global healthcare market
Exhibit 04: Market characteristics
Exhibit 05: Market segments
Exhibit 06: Market definition - Inclusions and exclusions checklist
Exhibit 07: Market size 2019
Exhibit 08: Global market: Size and forecast 2019-2024 ($ millions)
Exhibit 09: Global market: Year-over-year growth 2020-2024 (%)
Exhibit 10: Five forces analysis 2019
Exhibit 11: Five forces analysis 2024
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition - Five forces 2019
Exhibit 18: End-user - Market share 2019-2024 (%)
Exhibit 19: Comparison by end-user
Exhibit 20: Pharmaceutical companies - Market size and forecast 2019-2024 ($ millions)
Exhibit 21: Pharmaceutical companies - Year-over-year growth 2020-2024 (%)
Exhibit 22: Other organizations - Market size and forecast 2019-2024 ($ millions)
Exhibit 23: Other organizations - Year-over-year growth 2020-2024 (%)
Exhibit 24: Market opportunity by end-user
Exhibit 25: Customer landscape
Exhibit 26: Market share by geography 2019-2024 (%)
Exhibit 27: Geographic comparison
Exhibit 28: North America - Market size and forecast 2019-2024 ($ millions)
Exhibit 29: North America - Year-over-year growth 2020-2024 (%)
Exhibit 30: Top 3 countries in North America
Exhibit 31: Europe - Market size and forecast 2019-2024 ($ millions)
Exhibit 32: Europe - Year-over-year growth 2020-2024 (%)
Exhibit 33: Top 3 countries in Europe
Exhibit 34: Asia - Market size and forecast 2019-2024 ($ millions)
Exhibit 35: Asia - Year-over-year growth 2020-2024 (%)
Exhibit 36: Top 3 countries in Asia
Exhibit 37: ROW - Market size and forecast 2019-2024 ($ millions)
Exhibit 38: ROW - Year-over-year growth 2020-2024 (%)
Exhibit 39: Top 3 countries in ROW
Exhibit 40: Key leading countries
Exhibit 41: Market opportunity
Exhibit 42: Impact of drivers and challenges
Exhibit 43: Vendor landscape
Exhibit 44: Landscape disruption
Exhibit 45: Vendors covered
Exhibit 46: Vendor classification
Exhibit 47: Market positioning of vendors
Exhibit 48: Bilcare Ltd. - Vendor overview
Exhibit 49: Bilcare Ltd. - Business segments
Exhibit 50: Bilcare Ltd. - Key offerings
Exhibit 51: Bilcare Ltd. - Key customers
Exhibit 52: Caligor Coghlan Pharma Services - Vendor overview
Exhibit 53: Caligor Coghlan Pharma Services - Business segments
Exhibit 54: Caligor Coghlan Pharma Services - Organizational developments
Exhibit 55: Caligor Coghlan Pharma Services - Key offerings
Exhibit 56: Caligor Coghlan Pharma Services - Key customers
Exhibit 57: Corden Pharma International GmbH - Vendor overview
Exhibit 58: Corden Pharma International GmbH - Business segments
Exhibit 59: Corden Pharma International GmbH - Organizational developments
Exhibit 60: Corden Pharma International GmbH - Key offerings
Exhibit 61: Corden Pharma International GmbH - Key customers
Exhibit 62: Mawdsley-Brooks & Co. Ltd. - Vendor overview
Exhibit 63: Mawdsley-Brooks & Co. Ltd. - Business segments
Exhibit 64: Mawdsley-Brooks & Co. Ltd. - Organizational developments
Exhibit 65: Mawdsley-Brooks & Co. Ltd. - Key offerings
Exhibit 66: Mawdsley-Brooks & Co. Ltd. - Key customers
Exhibit 67: PCI Pharma Services - Vendor overview
Exhibit 68: PCI Pharma Services - Business segments
Exhibit 69: PCI Pharma Services - Organizational developments
Exhibit 70: PCI Pharma Services - Key offerings
Exhibit 71: PCI Pharma Services - Key customers
Exhibit 72: Piramal Enterprises Ltd. - Vendor overview
Exhibit 73: Piramal Enterprises Ltd. - Business segments
Exhibit 74: Piramal Enterprises Ltd. - Organizational developments
Exhibit 75: Piramal Enterprises Ltd. - Segment focus
Exhibit 76: Piramal Enterprises Ltd. - Key offerings
Exhibit 77: Piramal Enterprises Ltd. - Key customers
Exhibit 78: Sentry BioPharma Services - Vendor overview
Exhibit 79: Sentry BioPharma Services - Business segments
Exhibit 80: Sentry BioPharma Services - Key offerings
Exhibit 81: Sentry BioPharma Services - Key customers
Exhibit 82: Sharp - Vendor overview
Exhibit 83: Sharp - Business segments
Exhibit 84: Sharp - Organizational developments
Exhibit 85: Sharp - Geographic focus
Exhibit 86: Sharp - Key offerings
Exhibit 87: Sharp - Key customers
Exhibit 88: The WestRock group - Vendor overview
Exhibit 89: The WestRock group - Business segments
Exhibit 90: The WestRock group - Organizational developments
Exhibit 91: The WestRock group - Segment focus
Exhibit 92: The WestRock group - Key offerings
Exhibit 93: The WestRock group - Key customers
Exhibit 94: Thermo Fisher Scientific Inc. - Vendor overview
Exhibit 95: Thermo Fisher Scientific Inc. - Business segments
Exhibit 96: Thermo Fisher Scientific Inc. - Organizational developments
Exhibit 97: Thermo Fisher Scientific Inc. - Geographic focus
Exhibit 98: Thermo Fisher Scientific Inc. - Segment focus
Exhibit 99: Thermo Fisher Scientific Inc. - Key offerings
Exhibit 100: Thermo Fisher Scientific Inc. - Key customers
Exhibit 101: Validation techniques employed for market sizing
Exhibit 102: Definition of market positioning of vendors

Executive Summary

The following companies as the key players in the global CBD skincare market: Cannuka LLC, Cronos Group Inc., Elixinol Global Ltd., Endoca BV, Isodiol International Inc., Josie Maran Cosmetics LLC, Khiron Life Sciences Corp., L’Oréal SA, Medical Marijuana Inc. and The CBD Skincare Co.

Commenting on the report, an analyst from the research team said: “The latest trend gaining momentum in the market is growing demand among millennial and middle-aged populations”

According to the report, one of the major drivers for this market is the benefits of CBD in skincare.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.